Cargando…

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)

The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) chemotherapy for treatment of colorectal and head and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sihver, Wiebke, Pietzsch, Jens, Krause, Mechthild, Baumann, Michael, Steinbach, Jörg, Pietzsch, Hans-Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978494/ https://www.ncbi.nlm.nih.gov/pubmed/24603603 http://dx.doi.org/10.3390/ph7030311

Ejemplares similares

Maleimido-Functionalized NOTA Derivatives as Bifunctional Chelators for Site-Specific Radiolabeling
por: Förster, Christian, et al.
Publicado: (2011)

Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging †
por: Reissig, Falco, et al.
Publicado: (2020)

Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics
por: Gilpin, Ian Moore F., et al.
Publicado: (2021)

Preclinical Characterization of the (177)Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
por: Striese, Franziska, et al.
Publicado: (2023)

Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy
por: Reissig, Falco, et al.
Publicado: (2020)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
por: Reissig, Falco, et al.
Publicado: (2021)

Recent Trends in Bioorthogonal Click-Radiolabeling Reactions Using Fluorine-18
por: Pretze, Marc, et al.
Publicado: (2013)

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021)

Comparison of Conjugation Strategies of Cross-Bridged Macrocyclic Chelators with Cetuximab for Copper-64 Radiolabeling and PET Imaging of EGFR in Colorectal Tumor-Bearing Mice
por: Zeng, Dexing, et al.
Publicado: (2014)

From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
por: Albert, Susann, et al.
Publicado: (2018)

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
por: Benelli, Roberto, et al.
Publicado: (2022)

(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
por: Bergmann, Ralf, et al.
Publicado: (2016)

Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments (‡)
por: Neuber, Christin, et al.
Publicado: (2018)

Synthesis and evaluation of (64)Cu-radiolabeled NOTA-cetuximab ((64)Cu-NOTA-C225) for immuno-PET imaging of EGFR expression
por: Xu, Xiaoxia, et al.
Publicado: (2019)

Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II
por: Zhang, Keqiang, et al.
Publicado: (2020)

Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
por: Qian, Yichun, et al.
Publicado: (2014)

RUNX3 regulates the susceptibility against EGFR-targeted non-small cell lung cancer therapy using (47)Sc-conjugated cetuximab
por: Kim, Da-Mi, et al.
Publicado: (2023)

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab
por: Froelich, Matthias F., et al.
Publicado: (2018)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
por: Laube, Markus, et al.
Publicado: (2016)

Strategic Evaluation of the Traceless Staudinger Ligation for Radiolabeling with the Tricarbonyl Core
por: Mamat, Constantin, et al.
Publicado: (2021)

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy
por: Tseng, Shih-Heng, et al.
Publicado: (2015)

Radiopharmacologist’s and Radiochemist’s View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System
por: Neuber, Christin, et al.
Publicado: (2020)

Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer
por: Greene, Michelle K., et al.
Publicado: (2020)

Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes
por: Löser, Reik, et al.
Publicado: (2015)

Radiolabeled F(ab′)(2)-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
por: Bellaye, P.-S., et al.
Publicado: (2018)

Efficient Production of the PET Radionuclide (133)La for Theranostic Purposes in Targeted Alpha Therapy Using the (134)Ba(p,2n)(133)La Reaction
por: Brühlmann, Santiago Andrés, et al.
Publicado: (2022)

In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system
por: Leonidova, Anna, et al.
Publicado: (2015)

Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase
por: Kuchar, Manuela, et al.
Publicado: (2018)

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11
por: Judmann, Benedikt, et al.
Publicado: (2023)

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
por: Cappuzzo, F, et al.
Publicado: (2008)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013)

A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
por: Landi, Nicola, et al.
Publicado: (2023)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts
por: Sreeranganathan, Maya, et al.
Publicado: (2017)

Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors
por: Abdellatif, Ahmed A. H., et al.
Publicado: (2020)

An automated workflow for parallel processing of large multiview SPIM recordings
por: Schmied, Christopher, et al.
Publicado: (2016)

Novel Bifunctional Cyclic Chelator for (89)Zr Labeling–Radiolabeling and Targeting Properties of RGD Conjugates
por: Zhai, Chuangyan, et al.
Publicado: (2015)

Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells
por: Avvakumova, S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7kqorloo95nri9gmran7253gg